effective l carnitine dose Characteristics of included studies Amino acid TREC L-CARNITINE +

Cory, A.W

In some embodiments, the formulations or compositions described herein have a pH between about 5 and about 8, or between about 6 and about 7, or between about 6.5 and about 7, or between about 5.5 and about 7.5, or between about 7.1 and about 7.7, and have a concentration of active pharmaceutical ingredient between about 50 and about 80 mM

Sources: NIH Office of Dietary Supplements, NOW Foods Official Product Page

For dedicated appetite/weight management, melanocortin-based drugs like semaglutide or tirzepatide are far better studied in humans

Palatin Technologies (the developer) has launched a Phase II study in men with ED who are PDE5 inhibitor non-responders, using a new co-formulation of bremelanotide plus a PDE5i in a single injection